Deferred Tax Assets, Valuation Allowance of ADMA BIOLOGICS, INC. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ADMA BIOLOGICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • ADMA BIOLOGICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ADMA BIOLOGICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 -$101,422,000 -100% 31 Dec 2024 10-K 18 Mar 2025 2024 FY
Q4 2023 $101,422,000 +$4,697,000 +4.9% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q4 2022 $96,725,000 +$15,116,715 +19% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $81,608,285 +$14,618,762 +22% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q4 2020 $66,989,523 +$19,651,223 +42% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q4 2019 $47,338,300 +$11,790,031 +33% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q4 2018 $35,548,269 -$1,015,580 -2.8% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q4 2017 $36,563,849 -$751,505 -2% 31 Dec 2017 10-K 13 Mar 2019 2018 FY
Q4 2016 $37,315,354 +$5,755,413 +18% 31 Dec 2016 10-K 29 Mar 2018 2017 FY
Q4 2015 $31,559,941 +$6,021,614 +24% 31 Dec 2015 10-K 24 Feb 2017 2016 FY
Q4 2014 $25,538,327 +$45,929,410 31 Dec 2014 10-K 23 Mar 2016 2015 FY
Q4 2013 $20,391,083 -$6,850,118 -51% 31 Dec 2013 10-K 09 Mar 2015 2014 FY
Q4 2012 $13,540,965 -$1,382,999 -11% 31 Dec 2012 10-K 28 Mar 2014 2013 FY
Q4 2011 $12,157,966 31 Dec 2011 10-K 06 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.